logo

Recombinant DNA (rDNA) Technology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Recombinant DNA (rDNA) Technology Market is segmented by Product, Component (Expression System, Cloning Vector), Application, End User, and Geography.

Home Industry Reports Healthcare Recombinant DNA (rDNA) Technology Market - Growth, Trends, COVID-19 Impact, and ...

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Recombinant DNA technology (RDT) is essential for improving health conditions, primarily by developing new vaccines and pharmaceuticals. Moreover, the treatment strategies are improved by developing diagnostics kits, monitoring devices, and new therapeutic approaches. Additionally, many other industries are benefiting from the research conducted on genetically modified organisms (GMO), such as microorganisms that are considered as clean fuel producers and bio degraders. Genetically modified vaccines are developed for curing various diseases in humans and plants. The recombinant DNA technology created several potential innovation opportunities for developing a wide range of therapeutic products, with immediate effect in medical genetics and biomedicine, by modifying microorganisms, animals, and plants, in order to yield medically useful substances. Therefore, the increasing demand and application of RDT in various sectors are driving the growth of the market studied.

Scope of the Report

Recombinant DNA technology is a process in which creation and manipulation of the DNA sequences are in a specific order. This is resulting in the production of genetically modified organisms and products. The recombinant DNA is primarily used in conventional and non-conventional applications, such as medicinal, agricultural, and industrial. In medicine, recombinant DNA has been used for mass production of insulin, follistim, human growth hormones, monoclonal antibodies, human albumin, vaccines, and other drugs.

By Product
Medical
Therapeutic Agent
Human Protein
Vaccine
Non-medical
Biotech Crops
Specialty Chemicals
Other Non-medical Products
By Component
Expression System
Cloning Vector
By Application
Food and Agriculture
Health and Disease
Environment
Other Applications
By End User
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Food and Agriculture segment is Expected to Register the Highest CAGR over the Forecast period

In agriculture, the development of genetically modified crops, in order to improve both yield and resistance to pests or herbicides, is gaining a high degree of public acceptance. The genetically modified tomato, CGN-89564-2, was the first commercially grown, genetically engineered crop product to be granted a license for human consumption. Additionally, DNA molecular marker technology is important for preservation, identification, evaluation, mining, and innovation of plant germplasm resources. The introduction of a genetically modified fruit paved the way for the use of GMOs in food. Currently, genetic modification is witnessing a widespread adoption. Thus, increasing the application of RDT in agriculture and food is expected to drive the growth of the market studied.

Recombinant DNA (rDNA) Technology Market.png

The North American region is Expected to Dominate the Market Over the Forecast Period

The North American region is expected to dominate the market studied over the forecast period. In the North America region, the United States accounts for the largest market share, primarily due to the presence of numerous biopharmaceutical manufacturing companies and the presence of effective regulatory bodies to monitor the various ethical and scientific concerns, pertaining to the use of technology. This is expected to drive the market’s growth, especially in the North American region.

Recombinant DNA (rDNA) Technology Market - Growth Rate by Region

Competitive Landscape

The Recombinant DNA (rDNA) Technology market is competitive, with the presence of both major players and small players. In terms of market share, the major players are currently dominating the market. Some of the major market players include GenScript, New England Biolabs, GlaxoSmithKline Plc, Pfizer, and Sanofi, among others.

Recombinant DNA (rDNA) Technology Market com.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Genomics

      2. 4.2.2 Expansion of Biopharmaceutical Industry

      3. 4.2.3 Increasing Demand and Applications of Recombinant/ Genetically Modified Products

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory, Scientific, and Ethical Challenges Associated with Gene Therapy

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Medical

        1. 5.1.1.1 Therapeutic Agent

        2. 5.1.1.2 Human Protein

        3. 5.1.1.3 Vaccine

      2. 5.1.2 Non-medical

        1. 5.1.2.1 Biotech Crops

        2. 5.1.2.2 Specialty Chemicals

        3. 5.1.2.3 Other Non-medical Products

    2. 5.2 By Component

      1. 5.2.1 Expression System

      2. 5.2.2 Cloning Vector

    3. 5.3 By Application

      1. 5.3.1 Food and Agriculture

      2. 5.3.2 Health and Disease

      3. 5.3.3 Environment

      4. 5.3.4 Other Applications

    4. 5.4 By End User

      1. 5.4.1 Biotechnology and Pharmaceutical Companies

      2. 5.4.2 Academic and Government Research Institutes

      3. 5.4.3 Other End Users

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East & Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East & Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amgen Inc.

      2. 6.1.2 Eli Lilly and Company

      3. 6.1.3 F. Hoffmann-La Roche Ltd (Genentech Inc.)

      4. 6.1.4 GenScript

      5. 6.1.5 Merck KGaA

      6. 6.1.6 New England Biolabs

      7. 6.1.7 Novartis AG

      8. 6.1.8 Novo Nordisk A/S

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Sanofi

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Recombinant DNA (rDNA) Technology Market market is studied from 2018 - 2026.

The Recombinant DNA (rDNA) Technology Market is growing at a CAGR of 6.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

New England Biolabs, GlaxoSmithKline plc, Pfizer, Sanofi, GenScript are the major companies operating in Recombinant DNA (rDNA) Technology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!